| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |